A Vitiligo-like Cutaneous Reaction Induced by Ribociclib in Advanced Breast Cancer: An Unusual Case Report from Colombia
This case highlights the importance of early recognition and management of ribociclib-related cutaneous toxicities. A multidisciplinary approach is essential to minimize adverse effects without compromising therapeutic efficacy. Further research into the dermatologic manifestations of targeted therapies is needed to optimize patient care.
Authors
- Carlos Bermúdez (ORCID: https://orcid.org/0000-0002-1226-3735)
- Yamil Liscano (ORCID: https://orcid.org/0000-0002-2674-8725)
- Daniel Florez
- Giovanna Patricia Rivas Tafurt
- Sinthia Vidal-Cañas (ORCID: https://orcid.org/0009-0002-5656-9418)
- Jesús Lechuga Montenegro (ORCID: https://orcid.org/0000-0003-0012-7485)
- Miguel Ángel Diaz-Diaz
- Andres Felipe Bravo-Gustin
Institutions
- Universidad Santiago de Cali (CO)
- Universidad Autónoma de Occidente (CO)
Publication Details
- Journal
- Diseases
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3390/diseases13050158
- Citations
- 2
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Universidad Santiago de Cali